Skip to main content
. 2018 May 15;18:563. doi: 10.1186/s12885-018-4485-4

Table 3.

Univariate and multivariate analysis of prognostic factors for duodenal GISTs

Prognostic factors Univariate analysis Multivariate analysis
β Hazard ratio (95% CI) P value β Hazard ratio (95% CI) P value
DFS
 Age 0.480 1.616 (0.874–2.987) 0.126
 Gender −0.148 0.862 (0.470–1.582) 0.632
 Anatomical location 0.108 1.114 (0.744–1.666) 0.601
 Surgical procedure 1.517 4.559 (2.510–8.281) < 0.001
 Tumor size 1.441 4.224 (2.769–6.442) < 0.001 1.406 4.082 (1.979–8.416) < 0.001
 Mitotic index 2.049 7.759 (3.751–16.048) < 0.001 1.294 3.648 (1.375–9.680) 0.009
 NIH risk category 1.457 4.294 (2.394–7.702) < 0.001
 Adjuvant therapy 0.327 1.387 (0.514–3.742) 0.518
DSS
 Age 0.338 1.403 (0.596–3.300) 0.438
 Gender 0.324 1.383 (0.587–3.257) 0.459
 Anatomical location 0.107 1.113 (0.649–1.909) 0.697
 Surgical procedure 1.082 2.952 (1.274–6.837) 0.012
 Tumor size 1.629 5.100 (2.640–9.853) < 0.001 1.339 3.816 (1.743–8.354) 0.001
 Mitotic index 1.719 5.580 (2.277–13.674) < 0.001
 NIH risk category 1.035 2.815 (1.547–5.123) 0.001
 Adjuvant therapy −1.388 0.249 (0.033–1.877) 0.178

GIST: gastrointestinal stromal tumor; NIH: National Institutes of Health;

DFS: disease-free survival; DSS: disease-specific survival; CI: confidence interval